UNC93B1 Physically Associates with Human TLR8 and Regulates TLR8-Mediated Signaling by Itoh, Hiroki et al.
UNC93B1 Physically Associates with Human TLR8 and
Regulates TLR8-Mediated Signaling
Hiroki Itoh
., Megumi Tatematsu
., Ayako Watanabe
.¤, Katsunori Iwano, Kenji Funami, Tsukasa Seya,
Misako Matsumoto*
Department of Microbiology and Immunology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
Abstract
Toll-like receptors (TLRs) 3, 7, 8, and 9 are localized to intracellular compartments where they encounter foreign or self
nucleic acids and activate innate and adaptive immune responses. The endoplasmic reticulum (ER)-resident membrane
protein, UNC93B1, is essential for intracellular trafficking and endolysosomal targeting of TLR7 and TLR9. TLR8 is
phylogenetically and structurally related to TLR7 and TLR9, but little is known about its localization or function. In this study,
we demonstrate that TLR8 localized to the early endosome and the ER but not to the late endosome or lysosome in human
monocytes and HeLa transfectants. UNC93B1 physically associated with human TLR8, similar to TLRs 3, 7, and 9, and played
a critical role in TLR8-mediated signaling. Localization analyses of TLR8 tail-truncated mutants revealed that the
transmembrane domain and the Toll/interleukin-1 receptor domain were required for proper targeting of TLR8 to the early
endosome. Hence, although UNC93B1 participates in intracellular trafficking and signaling for all nucleotide-sensing TLRs,
the mode of regulation of TLR localization differs for each TLR.
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Introduction
The innate immune system discriminates self from non-self by
expressing germ-line encoded receptors that recognize pathogen- or
damage-associated molecular patterns [1-3]. The Toll-like receptor
(TLR) family of type I transmembrane proteins were the first group
of pattern recognition receptors to be identified [4]. Within this
family, TLRs 3, 7, 8, and 9 recognize microbial nucleic acids and
induce cytokine production, including type I interferon (IFN), and
dendritic cell (DC) maturation [2]. In humans, TLR7 and TLR9
are selectively expressed in B cells and plasmacytoid DCs, while
TLR3 and TLR8 are expressed in myeloid DCs [5–8].
TLR8 is phylogenetically and structurally related to TLR7
[9,10]; they both recognize ssRNA and an imidazoquinoline
compound [11–13]. In mice, TLR8 appears to be nonfunctional
in most tissues and cells, exceptfor the brain[14,15]. Human TLR8
is expressed in myeloid cells, such as monocytes, macrophages, and
myeloid DCs, and also, in regulatory T cells [6,16,17]. Upon
stimulation with synthetic ligands, human TLR8 activates NF-kB
via the adaptor protein MyD88, which leads to the induction of
proinflammatory cytokines but, not type I IFN [13]. In contrast,
human/mouse TLR7 strongly induces type I IFN production in
response to ssRNA and an imidazoquinoline compound. The
differential expression and cytokine profiles of human TLR8
compared with those of human/mouse TLR7 suggest that human
TLR8 plays a distinct role in the anti-viral immune response.
Notably, these nucleotide-sensing TLRs are localized to
intracellular compartments. Human TLR3 localizes to the early
endosome where it recognizes exogenous dsRNA and generates
signals via Toll/interleukin-1 receptor (TIR)-containing adaptor
molecule-1 (TICAM-1), also named TIR domain-containing
adaptor-inducing IFN-b [8,18–20]. A linker region between the
transmembrane domain and the TIR domain consisting of 26
amino acids determines the subcellular localization of human
TLR3 [21]. In contrast, the transmembrane domain is the main
determinant for intracellular localization of mouse TLR7 and
TLR9 [22,23]. The endoplasmic reticulum (ER)-resident mem-
brane protein, UNC93B1, physically associates with TLR7 and
TLR9 and delivers them to endolysosomes [24,25]. After the
trafficking of TLR7 and TLR9 from the ER to the endolysosome,
their ectodomains are cleaved to generate a functional receptor
[26,27]. UNC93B1 also interacts with TLR3 [24], but its role in
the intracellular trafficking of TLR3 remains undefined; however,
the interaction of UNC93B1 with the TLR3, 7, and 9
transmembrane regions is essential for the signaling function of
these TLRs [28,29]. In contrast, there is little information
concerning the subcellular localization and trafficking of human
TLR8.
In this study, we analyzed the subcellular localization of TLR8
in human monocytes and HeLa transfectants and demonstrated
that TLR8 was localized to the early endosome and the ER but
not to the late endosome or lysosome. Using a series of TLR8
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and the TIR domains are required for the intracellular localization
of TLR8. Furthermore, we showed that UNC93B1 physically
associates with TLR8 and regulates TLR8-mediated signaling.
Results
Human TLR8 localizes to the early endosome and the ER
in human monocytes
Intracellular expression of TLR8 was first analyzed using a
chimeric receptor composed of the extracellular domain of murine
TLR4 fused with the transmembrane and cytoplasmic regions of
murine TLR8 [22]. Subsequently, intact human TLR8 was shown
to localize intracellularly in transfected cells [30]. However, the
site of localization of TLR8 remained unknown. We therefore
analyzed the subcellular localization of human TLR8 in HeLa
cells transiently expressing FLAG-tagged human TLR8. When
examined using confocal microscopy, TLR8-positive compart-
ments colocalized with the early endosome antigen 1 (EEA1) and
the ER marker calreticulin (Fig. 1A). Late endosome (MPR),
lysosome (LAMP-1), and Golgi (p115) markers did not colocalize
with TLR8 (Fig. 1A and data not shown). TLR8 is expressed in
human monocytes and induces the cytokine production in
response to a synthetic TLR8 ligand [13]; therefore, we next
examined the subcellular localization of endogenous TLR8 in
human monocytes. TLR8 was localized to the early endosome and
the ER but not to the late endosome/lysosome or Golgi (Fig. 1B).
Thus, the localization site of TLR8 differed from TLR7 and
TLR9, both of which reside in the endolysosome and the ER.
The TIR domain is required for endosomal localization of
human TLR8
To determine which region is responsible for the intracellular
localization and trafficking of human TLR8, we constructed tail-
truncated mutants (Fig. 2A). These included a mutant lacking the
TIR domain but retaining the proximal 31 amino acids (delTIR,
1–896 a.a.), one that lacked the cytoplasmic tail (delCYT, 1–866
a.a.), and a mutant lacking the transmembrane domain and the
cytoplasmic tail, which anchors the receptor to the membrane via
glycosylphosphatidylinositol (GPI) (GPI-TLR8, 45–843 a.a.)
(Fig. 2A). When transiently expressed in HEK293FT cells, these
mutant proteins were expressed with the expected molecular
weight (Fig. 2B). Immunofluorescence staining of HeLa transfec-
tants with anti-FLAG mAb showed that both delTIR and delCYT
were displayed on the cell surface (Fig. 2C), while GPI-TLR8
resided only in the ER (Fig. 2C). The lack of expression of GPI-
TLR8 on the cell surface was confirmed by flow cytometric
analysis with an anti-FLAG mAb (Fig. S1). These results suggest
that both transmembrane and the TIR domains are required for
proper targeting of human TLR8 to the early endosome.
UNC93B1 physically associates with human TLR8
The ER membrane protein UNC93B1 interacts with TLR3,
TLR7, and TLR9 in the ER through the transmembrane domain,
and is critical for signaling by these TLRs. Imaging analyses
revealed that UNC93B1 regulates intracellular trafficking and
endolysosomal targeting of TLR7 and TLR9 [25]. However, its
participation in TLR8 localization and signaling remains un-
known. To determine the role of UNC93B1 in TLR8 function, we
constructed an additional two TLR4/8 chimeric receptors and
examined physical interaction between human UNC93B1 and
wild-type TLR8, TLR4/8 chimeric receptors, or tail-truncated
mutants using co-immunoprecipitation analysis. Chimera
TLR4ecto/8 comprised the extracellular domain of TLR4 and
the transmembrane and cytoplasmic regions of TLR8, while
chimera TLR4/8TIR was composed of the extracellular,
transmembrane, and linker regions of TLR4 and the TIR domain
of TLR8 (Fig. 3A). As shown in Figure 3B, wild-type TLR8
protein co-immunoprecipitated with UNC93B1 protein in
HEK293FT cell lysates, similar to the TLR3 protein. In addition,
the TLR4ecto/8 chimeric protein, but not TLR4 and TLR4/
8TIR proteins, physically associated with UNC93B1, indicates
that the transmembrane region of TLR8 is required for interaction
with UNC93B1 (Fig. 3B). Consistent with these results, the TLR8
mutant delCYT associated with UNC93B1, while GPI-TLR8
failed to interact with UNC93B1 (Fig. 3C).
UNC93B1 colocalizes with surface-expressed TLR8
mutants
Since delTIR and delCYT appeared on the cell surface
(Fig. 2C), we next examined whether UNC93B1 translocates
from the ER to the plasma membrane when these mutants were
forcibly expressed in HeLa cells. Interestingly, confocal imaging
analysis clearly demonstrated that endogenous UNC93B1 was
colocalized with delTIR and delCYT at the plasma membrane,
whereas wild-type TLR8 colocalized with UNC93B1 intracellu-
larly (Fig. 4A).
Notably, delTIR and delCYT mutants performed as a
dominant-negative against wild-type TLR8. As illustrated in
Figure 4B, TLR8-mediated NF-kB activation induced with the
TLR8 ligand, CL075 (a thiazoloquinolone derivative), was
inhibited by the expression of either delTIR (Fig. 4B, upper
graph) or delCYT (Fig. 4B, middle graph) in a dose-dependent
manner. In contrast, the expression of GPI-TLR8 did not affect
CL075-induced NF-kB activation mediated by wild-type TLR8
(Fig. 4B, lower graph). Thus, the delTIR and delCYT mutants
appeared to interfere with the exit of wild-type TLR8 from the
ER. Indeed, there was minimal overlay of wild-type TLR8 with
EEA1 when co-expressed with these mutants (Fig. S2).
UNC93B1 is essential for TLR8-mediated signaling
Next, we investigated whether UNC93B1 was involved in
TLR8-mediated signaling. CL075-induced TLR8-mediated NF-
kB activation was greatly increased by the co-expression of
UNC93B1 (Fig. 5A). Inversely, knockdown of endogenous
UNC93B1 in HEK293 cells downregulated CL075-induced
TLR8-mediated NF-kB activation (Fig. 5B). Thus, UNC93B1 is
indispensable for TLR8 signaling.
Given that signaling via TLRs 3, 7, and 9 was disrupted in 3d
mice, which expresses a UNC93B1 missense mutant (H412R)
incapable of TLR binding [29], we constructed a human
UNC93B1 mutant, hUNC93B1(H412R), and examined its ability
Figure 1. Subcellular localization of TLR8 in human monocytes and HeLa transfectants. HeLa cells transiently expressing human TLR8 (A)
and human monocytes (B) were incubated with anti-FLAG mAb (A) or anti-TLR8 mAb (B) followed by an Alexa Fluor 488-conjugated secondary Ab.
Organelles were stained with an anti-EEA1 pAb, anti-MPR pAb, anti-p115 pAb, anti-calreticulin pAb, or anti-calnexin pAb followed by an Alexa Fluor
568-conjugated secondary Ab. Representative confocal images are shown. Green, TLR8; red, organelle markers; blue, nuclei stained with DAPI. Scale
bar: (A)1 0mm; (B)5mm.
doi:10.1371/journal.pone.0028500.g001
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failed to interact with human TLR8, similar to human TLR3
(Fig. 6A). Additionally, forced expression of hUNC93B1(H412R)
did not augment CL075-induced TLR8-mediated NF-kB activa-
tion (Fig. 6B), suggesting that association of human UNC93B1
with TLR8 through His412 is required for TLR8-mediated
signaling as was observed with mouse UNC93B1.
Discussion
Nucleotide-sensing TLRs are divided into two groups based on
their distribution profiles in DCs. In humans, TLR3 and TLR8
are expressed in myeloid DCs, while TLR7 and TLR9 are
expressed in plasmacytoid DCs [6]. Although TLR8 belongs to the
TLR7/8/9 subfamily, the present study demonstrated that TLR8
possesses properties distinct from those of TLR7 and TLR9. First,
TLR8, like TLR3, is localized to the early endosome but not in the
late endosome/lysosome, where TLR7 and TLR9 reside. Second,
although TLR8 requires UNC93B1 to exit from the ER, the TIR
domain determines the endosomal targeting of TLR8.
In mouse macrophages and DCs, TLR7 and TLR9 exit the ER
and travel to endolysosomes where the ectodomains of both
proteins are cleaved to generate functional receptors [26,27].
UNC93B1 controls intracellular trafficking of TLR7 and TLR9
[25,28]. It is obvious that UNC93B1 physically interacts with
TLR3, TLR7, and TLR9 in the ER through the transmembrane
domain, and is critical for signaling of these TLRs in mice [24,29].
However, prior to this study, it was unclear whether UNC93B1
was involved in TLR8-mediated signaling. We demonstrated the
interaction of human UNC93B1 with human TLR8 using a co-
immunoprecipitation assay and showed that the up-regulation of
TLR8-mediated NF-kB activation in HEK293 cells was induced
by the ectopic expression of UNC93B1 (Figs. 3 and 5). The
H412R mutation within the transmembrane domain of UNC93B1
disrupted interaction between UNC93B1 and TLR8, and thus
failed to increase TLR8-mediated signaling (Fig. 6). Finally,
knockdown analysis revealed that UNC93B1 is indispensable for
TLR8-mediated signaling (Fig. 5B).
Although UNC93B1 has been shown to deliver TLR7 and
TLR9 to endolysosomes where the receptors are cleaved by
proteases, this is not the case for TLR8 or TLR3. Gibbard et al.
showed that the intact ectodomain of human TLR8 is necessary
for dimerization of the receptor and induction of NF-kB activation
in response to a synthetic ligand, CL075, in monocytes and
HEK293 cells [30]. Hence, TLR8 seems to differ from TLR7 and
TLR9 in its mode of ligand recognition. Interestingly, confocal
analysis of TLR8 tail-truncated mutants demonstrated that
endogenous UNC93B1 moved from the ER to the plasma
membrane with the TLR8 mutants. In wild-type TLR8, the
TIR domain controls the targeting of TLR8 to the early
endosome, although UNC93B1 is required for TLR8 exit from
the ER.
The nucleotide-sensing TLRs use different regulatory elements
for intracellular localization. In the case of mouse TLR7 and
TLR9, the transmembrane domain determines the intracellular
localization of the receptor. However, Leifer et al. reported that
the cytoplasmic tail of human TLR9 controls intracellular
localization [31]. A 14-amino acid region in the hTLR9-TIR
domain targets the Tac (human CD25)-TLR9 chimeric receptor
to early endosomes. Additionally, a recent report demonstrated
that bovine TLR8 localized to the ER, and that multiple regions,
including ectodomain, transmembrane, linker, and TIR regions of
bovine TLR8, are involved in determining the intracellular
localization [32]. Thus, there may be species-specific regulatory
mechanisms of intracellular localization of TLRs.
The mechanism by which TLR8 is retained in the early
endosome is currently unknown. It is likely that an unidentified
Figure 2. Defining the TLR domain responsible for localization.
A, Schematic diagram of the tail-deletion constructs of hTLR8. B,
Expression of the TLR tail-deletion constructs in HEK293FT cells. Wild-
type and mutant proteins transiently expressed in HEK293FT cells were
immunoprecipitated with anti-FLAG mAb, resolved using SDS-PAGE,
and detected using immunoblotting with anti-FLAG mAb. Molecular
weight markers are shown on the right. C, Immunofluorescence images
of the TLR8 deletion constructs in transfected HeLa cells. The upper and
middle panels show cells stained with delTIR and delCYT together with
phalloidin, which labels the plasma membrane. The lower two panels
show cells stained with GPI-TLR8 together with EEA1 or calreticulin.
Green, TLR8 mutants; red, organelles; blue, nuclei stained with DAPI;
bar, 10 mm.
doi:10.1371/journal.pone.0028500.g002
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trafficking to the early endosomes. As the BB loop in the TLR-
TIR domain is critical for interaction with adaptor proteins,
another region of the TLR8-TIR domain may participate in the
association with the protein(s) regulating the receptor trafficking
and intracellular localization of TLR8.
In humans, TLR7 and TLR8 recognize sequence-specific
ssRNA and imidazoquinoline compounds in distinct cells and
organelles, resulting in the induction of different immune
responses via the same adaptor protein, MyD88. TLR7 ligands
induce IFN-a production by plasmacytoid DCs, while TLR8
ligands induce proinflammatory cytokine production (e.g., TNF-a
and IL-6) by myeloid DCs and monocytes [13]. This implies that
TLR7 and TLR8 play distinct roles in the anti-viral immune
response. Myeloid DCs express the viral RNA sensors, TLR3 and
TLR8, on the endosomal membrane where they recognize virus-
derived dsRNA and ssRNA, respectively. Activation of TLR3 by
dsRNA results in the production of T helper 1 cytokines, such as
IFN-a/b and interleukin (IL)-12p70, as well as DC maturation
leading to the activation of cytotoxic T lymphocytes and natural
killer (NK) cells [33]. TLR3 activation also induces TICAM-1-
dependent gene expression in myeloid DCs, which mediates DC–
NK reciprocal activation through cell–cell contact independently
of type I IFN and IL-12 [34], whereas the key role of TLR8-
mediated myeloid DC activation remains poorly understood.
Detailed analyses of TLR8-mediated signaling in different cell
types may give us new insight into the function of TLR8 in the
anti-viral response.
Materials and Methods
Cell culture and reagents
HEK293 cells were maintained in Dulbecco’s Modified Eagle’s
medium low glucose (Invitrogen) supplemented with 10% heat-
inactivated FCS (BioSource Intl., Inc.) and antibiotics.
HEK293FT cells were maintained in Dulbecco’s Modified Eagle’s
medium high glucose supplemented with 0.1 mM NEAA, 10%
heat-inactivated FCS and antibiotics. HeLa cells were maintained
in Eagle’s MEM (Nissui, Tokyo, Japan) supplemented with 1% L-
glutamine and 10% heat-inactivated FCS. Human monocytes
were isolated from peripheral blood mononuclear cells obtained
from healthy individuals with a magnetic cell sorting system using
anti-CD14-coated microbeads (Miltenyi Biotec, Gladbach, Ger-
many). Anti-FLAG M2 monoclonal antibody (mAb), anti-HA
polyclonal Ab (pAb), 49,6-diamidine-29-phenylindole dihydrochlo-
ride (DAPI), TRITC-labeled anti-phalloidin Ab, and saponin were
purchased from Sigma-Aldrich. In addition, the following
antibodies were used in this study: Alexa Fluor-conjugated
secondary antibodies (Invitrogen), anti-HA mAb (Covance), anti-
early endosome antigen 1 (EEA1) pAb (Affinity Bioreagents), anti-
calnexin pAb and anti-calreticulin pAb (Stressgen, Victoria,
Canada), anti-p115 pAb (Calbiochem, Darmstadt, Germany),
Figure 3. UNC93B1 physically associates with TLR8 through the
transmembrane domain in HEK293FT cells. A, Schematic diagram
of the TLR4/8 chimeric receptor constructs. B, C, HEK293FT cells were
transfected with the corresponding vectors for expression of the
indicated proteins. Twenty-four hours after transfection, cells were lysed
in lysis buffer. The lysates were immunoprecipitated (IP) with anti-HA
pAb (B) or anti-FLAG pAb (C), resolved using SDS-PAGE, and detected
using immunoblotting (IB) with anti-FLAG M2 mAb or anti-HA mAb.
Whole cell lysates (WCL) were subjected to immunoblotting with anti-
FLAG mAb (B) or anti-HA mAb (C) to detect protein expression.
Molecular weight markers are shown on the right.
doi:10.1371/journal.pone.0028500.g003
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bridge, UK), anti-human TLR8 mAb (Dendritics, LYON, France)
and anti-human UNC93B1 pAb (ProSci Inc., Poway, CA).
Lysotracker was from Invitrogen. CL075 was from InvivoGen.
Plasmids
Complementary DNAs for human TLR3 and TLR8 were
cloned in our laboratory by RT-PCR from the mRNA of
monocyte-derived immature DCs and were ligated into the
cloning site of the expression vector, pEF-BOS, which was
provided by Dr. S. Nagata (Kyoto University). The FLAG-tag or
HA-tag was inserted into the C-terminal of pEF-BOS expression
vectors for hTLR3 or hTLR8. The truncated TLR8 mutants,
delTIR (1-896 a.a.) and delCYT (1-866 a.a.) were generated by
PCR with Pfu Turbo DNA polymerase (STRATAGENE) using
specific primers (forward primer; 59-GACTACAAAGACGAT-
GACGACAAGTAAGCG-39, reverse primer for delTIR; 59-
GAAAGTTTGCGATGTGGAAAGAGACCTGTA-39, reverse
primer for delCYT; 59-AGCCAGGGCAGCCAACATAAC-
CATGGTGGT-39) as described [21]. GPI-hTLR8 was construct-
ed in the pEF-BOS expression vector by ligation of PCR products
corresponding to the TLR8 ectodomain (45-843 a.a.) sequentially
attached with the preprotrypsin signal sequence, HAT, and Flag at
the N-terminus, and the GPI-attachment sequence from CD55 at
Figure 4. UNC93B1 colocalizes with surface-expressed TLR8 mutants. A, HeLa cells transiently expressing wild-type TLR8, delCYT, or delTIR
were incubated with anti-FLAG mAb and anti-human UNC93B1 pAb followed by an Alexa Fluor 568-conjugated anti-mouse IgG and Alexa Fluor 488-
conjugated anti-rabbit IgG. Representative confocal images are shown. Green, endogenous UNC93B1; red, TLR8; blue, nuclei stained with DAPI. Scale
bar:10 mm. B, Surface-expressed TLR8 mutant proteins inhibited CL075-induced TLR8-mediated NF-kB activation. Luciferase activity of HEK293 cells
transfected with the ELAM-promoter-luciferase reporter and expression plasmid for wild-type TLR8 together with increasing amounts of plasmid
expressing delTIR (upper graph), delCYT (middle graph), or GPI-TLR8 (lower graph). Twenty-four hours after transfection, the cells were stimulated
with 2.5 mg/mL of CL075 or left untreated. After 24 hours, the luciferase reporter activities were measured and expressed as the fold induction
relative to the activity of unstimulated cells. Representative data from a minimum of three separate experiments are shown (mean and s.d. of
triplicate assays).
doi:10.1371/journal.pone.0028500.g004
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8, was constructed in the expression vector pEF-BOS by ligation of
PCR products corresponding to amino acids 1-633 of human
TLR4 ectodomain and amino acids 844-1059 of human TLR8.
Another TLR4/TLR8 chimeric receptor, TLR4/8TIR, was
constructed by the ligation of PCR products corresponding to
amino acids 1-672 of human TLR4 (ectodomain, TM, and linker
region) and amino acids 897-1059 of the human TLR8 TIR
domain. Both constructs were FLAG tagged at the C-terminus. A
plasmid for human UNC93B1 (pMD2/UNC93B1) and the
expression plasmid for TLR4 (pEF-BOS/TLR4) were provided
by Dr. K. Miyake (The University of Tokyo). The HA-tag was
inserted into the C-terminal of the pEF-BOS expression vector for
human UNC93B1. The human UNC93B1 mutant,
hUNC93B1(H412R), in which the arginine residue at position
412 was substituted for a histidine residue, was made by site-
directed mutagenesis.
Confocal microscopy
HeLa cells (1.0610
5 cells/well) were plated onto micro cover
glasses (Matsunami, Tokyo, Japan) in a 24-well plate. The
following day, cells were transfected with the indicated plasmids
using Fugene HD (Roche Diagnostics) or Lipofectamine 2000
(Invitrogen). Twenty-four hours after transfection, cells were fixed
with 3% formalin for 30 min and permeabilized with PBS
containing 0.5% saponin and 1% BSA for 30 min or fixed with
4% paraformaldehyde for 30 min and permeabilized with PBS
containing 0.2% Triton X-100 and 1% BSA for 15 min (for
staining of endogenous UNC93B1). In the case of monocytes, cells
were fixed with 4% paraformaldehyde for 15 min. For the staining
of late endosome, cells were permeabilized with PBS containing
100 mg/ml of digitonin and 1% BSA for 30 minutes. Fixed cells
were blocked in PBS containing 1% BSA, and were then labeled
with the indicated primary Abs (2,10 mg/ml) for 60 min at room
temperature. Alexa-conjugated secondary Abs (1:400) were used
Figure 5. UNC93B1 is indispensable for TLR8-mediated signaling. A, Upregulation of TLR8-mediated NF-kB activation by co-expression with
UNC93B. HEK293 cells were transfected with the indicated plasmid together with the ELAM reporter plasmid. Twenty-four hours after transfection,
the cells were stimulated with CL075 or left untreated. After 6 hours, the luciferase reporter activities were measured and expressed as the fold
induction relative to the activity of unstimulated cells. Representative data from three separate experiments are shown. B, TLR8-mediated NF-kB
activation is downregulated by knockdown of UNC93B1. UNC93B1 siRNA or negative control siRNA was transfected into HEK293 cells together with
the reporter plasmids and TLR8 expression plasmid. Forty-eight hours after transfection, cells were stimulated with CL075 for 6 hours and the
luciferase reporter activities were measured. Data are representative of three independent experiments (mean and s.d. of triplicate assays). The
expression of endogenous UNC93B1 and GAPDH mRNAs were examined using RT-PCR 48 hours after siRNA transfection (right panels).
doi:10.1371/journal.pone.0028500.g005
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ProLong Gold with DAPI (Molecular Probes), cells were visualized
at a magnification of 663 with an LSM510 META microscope
(Zeiss, Jena, Germany).
Reporter assay
HEK293 cells (5610
5 cells/well) cultured in 24-well plates were
transfected with the indicated plasmid together with the reporter
plasmid and an internal control vector, phRL-TK (Promega),
using FuGENE HD. The reporter plasmid containing the ELAM-
1 promoter was constructed in our laboratory. Twenty-four hours
after transfection, cells were stimulated with 2.5 mg/mL CL075.
The cells were collected 6 hours after stimulation and then lysed.
The Firefly and Renilla luciferase activities were determined using a
dual-luciferase reporter assay kit (Promega). The Firefly luciferase
activity was normalized with the Renilla luciferase activity and was
expressed as the fold induction relative to the activity in
unstimulated vector-transfected cells. All assays were performed
in triplicate.
RNAi
siRNA duplexes (UNC93B1:ID #s37730, negative control:
catalog #AM4635) were obtained from Ambion-Applied Biosys-
tems. HEK293 cells cultured in 24-well plates were transfected with
20 pmol of each siRNA together with the expression vector for
hTLR8 (40 ng), ELAM reporter plasmid (60 ng), an internal control
vector (1.5 ng) and empty vector (400 ng) using Lipofectamin 2000.
Forty-eight hours after transfection, cells were washed once and then
stimulated with 2.5 mg/ml CL075 for 6 hours. Knockdown of
UNC93B1 wasconfirmed 48 hoursaftersiRNA transfection byRT-
PCR using specific primers (UNC93B1: forward primer 59-
GCCCATGATTTATTTCCTGAACCACTACC-39 and reverse
primer,59-GTGTGCTGAGTCCAGTCTTGTTCAG-39,GA PD -
H: forward primer 59-GAGTCAACGGATTTGGTCGT-39 and
reverse primer 59- TTGATTTTGGAGGGATCTCG-39). Exper-
iments were repeated three times for confirmation of the results.
Immunoprecipitation
HEK293FT cells (2.5610
5 cells/well) cultured in 12-well plates
were transfected with the indicated plasmids using Lipofectamine
2000 (Invitrogen). After 24 hours, cells were washed twice with
DPBS. Washed cells were lysed in 1% digitonin lysis buffer
(50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 5 mM EDTA, 2 mM
PMSF, and a protease inhibitor cocktail) or 1% NP-40 lysis-
washing buffer (50 mM Tris-HCl (pH 7.4), 150 mM NaCl,
10 mM EDTA, 1 mM PMSF, and a protease inhibitor cocktail)
in Fig. 2. Lysates were clarified by centrifugation, pre-cleared with
Protein G-Sepharose (GE Healthcare, Buckinghamshire, UK),
and incubated with anti-FLAG mAb or anti-HA pAb. The
immunoprecipitates were recovered by incubation with Protein G-
Sepharose, washed three times with 0.1% digitonin washing buffer
(50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 5 mM EDTA, 1 mM
PMSF) or 1% NP-40 lysis-washing buffer and then resuspended in
denaturing buffer. Samples were analyzed by SDS-PAGE under
reducing conditions followed by immunoblotting with anti-tag
Abs.
Supporting Information
Figure S1 Flow cytometric analysis of cell surface expression of
GPI-hTLR8 transiently expressed in HeLa cells. HeLa cells were
Figure 6. His412 is essential for the interaction of UNC93B1 with TLR8 and TLR8-mediated signaling. A, HEK293FT cells were transfected
with the corresponding vectors for expression of the indicated proteins. The cell lysates were immunoprecipitated (IP) with anti-HA pAb, resolved by
SDS-PAGE and detected by immunoblotting (IB) with anti-FLAG M2 or anti-HA mAb. Whole cell lysates (WCL) were subjected to immunoblotting with
anti-FLAG or anti-HA mAb to detect protein expression. Molecular weight markers are shown on the right. B, HEK293 cells were transfected with the
indicated plasmid together with the ELAM reporter plasmid. Cells were stimulated with CL075 or left untreated and the luciferase reporter activities
were measured. Representative data from three separate experiments are shown. Lower panels, protein expression of wild-type and mutant UNC93B1
in HEK293 cells. b-actin blots are shown as loading controls.
doi:10.1371/journal.pone.0028500.g006
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PLoS ONE | www.plosone.org 8 December 2011 | Volume 6 | Issue 12 | e28500transfected with the empty vector or the expression plasmid for
FLAG-tagged GPI-hTLR8 using Lipofectamine 2000 in 12-well
plates. Twenty-four hours after transfection, cells were washed and
incubated with anti-FLAG M2 mAb or mouse IgG1 in the
presence of human IgG for 30 min at 4˚C in FACS buffer (DPBS
containing 0.5% BSA and 0.1% sodium azide). Cells were washed
twice in FACS buffer and incubated with FITC-labeled secondary
antibody (American Qualex) for 30 min at 4˚C. For intracellular
staining, cells were permeabilized with permeabilizing solution
(BD) for 10 min at room temperature, and then stained with anti-
FLAG mAb in the presence of 10% goat serum and FITC-labeled
secondary Ab. Cells were analyzed using a FACS Calibur (BD).
Shaded histogram: control mouse IgG 1 staining; thick line: anti-
FLAG mAb staining. Inset values indicate the mean fluorescent
intensities specific for the anti-FLAG mAb.
(EPS)
Figure S2 Forced expression of TLR8 mutants affects the
endosomal localization of wild-type TLR8. A, Confocal images
show HeLa cells co-expressing HA-tagged wild-type TLR8 and
FLAG-tagged TLR8 mutants. Cells were fixed and stained with
anti-FLAG mAb and anti-HA pAb, followed by Alexa568-labeled
goat anti-mouse Ab and Alexa488-labeled goat anti-rabbit Ab.
TLR8 mutants delCYT and delTIR were anchored on plasma
membrane and did not merge with wild-type TLR8. Red, TLR8
mutants; green, wild-type TLR8; blue, nuclei stained with DAPI;
bar, 10 mm. B, Cells were transfected with FLAG-tagged wild-type
TLR8 alone (upper panels), together with FLAG-tagged delCYT
(middle panels) or FLAG-tagged delTIR (lower panels), and
stained with anti-FLAG mAb and anti-EEA1 pAb, followed by
Alexa568-labeled goat anti-mouse Ab and Alexa488-labeled goat
anti-rabbit Ab. Wild-type TLR8 was expressed intracellularly and
colocalized with EEA1 (upper panels). When delCYT or delTIR
was expressed with wild-type TLR8, colocalization between TLR8
and EEA1 was decreased (middle and lower panels). Red, TLR8;
green, early endosome marker EEA1; blue, nuclei stained with
DAPI; bar, 10 mm.
(EPS)
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